Tirzepatide/Pyridoxine 20mg/mL (30mg)

About Tirzepatide

Tirzepatide is a promising advancement in medication with a great potential for weight loss. It is an injectable medication that’s prescribed to adults with type 2 diabetes mellitus.

Used along with a healthy diet and regular exercise, it has several roles, like:

• helping in weight loss
• suppressing appetite
• controlling blood sugar
• increasing insulin release
• decreasing glucagon release

Mechanism of Action

This drug activates two key receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (Glucagon-like peptide 1).

Though tirzepatide was created to treat type 2 diabetes, new research shows it may also be one of the best weight loss drugs available.

It works through three main mechanisms.

• First, it stimulates the growth of beta cells in the pancreas. These cells produce insulin, which helps the body regulate blood sugar levels more effectively.
• Second, it delays gastric emptying. This reduces the user’s appetite.
• Lastly, it helps people control their eating habits and significantly reduces food cravings.

This makes it distinct in its approach when compared with other medicines, and it may have better effects than those treatments because it targets both of these receptors at the same time.

It’s a very useful choice for people who want to lose weight while maintaining good general health.

Please note: It’s strictly advised not to use tirzepatide with other GLP-1 receptor agonist medications.

Why It’s Prescribed

Tirzepatide is usually prescribed because of its superior results in reducing A1C levels.

A1C is a critical measure of blood sugar control in people with diabetes, and its high levels can lead to severe complications such as blindness and cardiovascular events.

Many patients presenting with high A1C levels struggle to achieve proper glycemic control – tirzepatide is an option to address that issue.

Tirzepatide (combining a GLP-1 receptor agonist with a GIP) can help lower blood sugar more effectively than other medications like semaglutide. GIP increases insulin production, allowing the body to better control blood sugar levels.

What Makes It Unique

Tirzepatide leads to about an average weight loss of 20% in overweight people or those dealing with obesity, which sets it apart from other medications.

It’s also the first drug that targets both GLP-1 and GIP, extending more convincing glycemic control and appetite suppression than alternatives.

The weight loss it induces, plus its metabolic effects, in general, tend to be greater than what is seen with medications like semaglutide, with results improving as the dosage increases.